Abstract
Molecular point-of-care (POC) testing is defined as the diagnostic testing of acute-care parameters at or close to the patients „bed side" [1]. The development of POC technologies and platforms aims to speed up diagnosis time to start targeted therapeutic treatments without a lag in time caused by the transport of samples to external laboratories as well as lengthy analytical methods. This article describes an enabling approach based on reversed purification of nucleic acids resulting in a fast sample analysis and a miniaturized disposable sample cartridge.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
